Chinese scientists have achieved a major breakthrough in secure communications by successfully demonstrating tamper proof quantum data transmission over more than one hundred kilometres of optical fibre, using individual atoms rather than conventional electronic devices. The achievement marks a significant advance toward ultra
China’s humanoid robot makers are rapidly shifting their priorities from physical movement and mechanical design to advanced artificial intelligence, as the race to commercialise humanoid robots enters a decisive new phase. Companies across the sector are now betting that smarter “brains”, rather than
The European Union has formally charged TikTok with breaching its online content rules, accusing the video sharing app of using addictive design features that may harm users, particularly children and teenagers. Regulators have warned that TikTok must change the way its app works
China fintech giant Ant Group has moved deeper into advanced robotics by open sourcing its first artificial intelligence models designed to operate beyond controlled lab environments and into real world industrial settings. The release marks a strategic shift as Ant looks to extend
China’s humanoid robot industry is accelerating faster than expected, with new forecasts pointing to a sharp increase in unit sales as production costs fall and commercial adoption widens. A revised outlook from a major US investment bank now expects China’s humanoid robot sales
AstraZeneca has unveiled a 15 billion dollar investment plan in China, underscoring renewed commercial momentum between Beijing and London as the UK prime minister visits the country. The British Swedish pharmaceutical group said the investment, running through 2030, will expand medicines manufacturing and
China’s approach to cybersecurity is undergoing a structural transformation in 2026. What once centered on defending networks against breaches and malicious activity is now being repositioned as a foundational element of national digital strategy. Cybersecurity is no longer treated as a technical function
China’s manufacturing sector is entering a phase where scale alone is no longer sufficient to maintain competitiveness. Rising labor costs, an aging workforce, and tighter global supply chains are reshaping how factories operate. In this environment, industrial robotics is moving from a tool
China could become one of the first countries globally to approve a drug entirely designed by artificial intelligence, signalling a major shift in how new medicines are discovered and developed. Pharmaceutical executives say advances in AI and human genetics are accelerating China’s transition
China’s cell therapy sector is drawing renewed investor interest as NewCure Biotech raised more than 200 million yuan, or about $28 million, in a Series B financing round to accelerate development of its TCR T pipeline targeting solid tumors. The round was co
